SARS-CoV-2 vaccine breakthrough reinfection in a health-care worker of Iraq: A case report-Reference-Cited by-同舟云学术

SARS-CoV-2 vaccine breakthrough reinfection in a health-care worker of Iraq: A case report

Published:2022-04-13 Issue:5 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Hasan Dlshad Abdullah¹,Maulud Sazan Qadir²^ORCID,Jalal Paywast Jamal³,Priyanka ⁴^ORCID,Choudhary Om Prakash⁵^ORCID

Affiliation:

1. Public Health Laboratory Management-Erbil, Kurdistan Region of Iraq

2. Department of Biology, College of Education, Salahaddin University-Erbil, Erbil, Kurdistan Region of Iraq

3. Department of Biology, College of Science, University of Sulaimani, Sulymani, Kurdistan Region of Iraq

4. Department of Veterinary Microbiology, Mahatma Jyotiba Fule College of Veterinary and Animal Sciences, Jaipur, India

5. Department of Veterinary Anatomy and Histology, College of Veterinary Sciences and Animal Husbandry, Central Agricultural University (I), Selesih, Aizawl, India

Funder

The author(s) reported that there is no funding associated with the work featured in this article

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2055947

Reference16 articles.

1. COVID‐19 reinfection in a healthcare worker after exposure with high dose of virus: A case report

2. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants

3. Centers for Disease Control and Prevention; [accessed 2022 Jan 31]. https://www.cdc.gov/mmwr.

4. Possible COVID-19 reinfection case in Duhok City, Kurdistan: A case report

5. Case Report: Reinfection of COVID-19, with second infection less severe

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants;PLOS ONE;2023-12-07